KYLEEN SCHMOKER: Open Payments
NPI 1164187811 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 31 payments from 10 companies in 2025. Trend: 2023 $940 · 2024 $834 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $147 |
| Lilly USA, LLC | 4 | $81 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Mannkind Corporation | 1 | $35 |
| Antares Pharma, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Auvelity, QULIPTA, UBRELVY, TZIELD, REXULTI, JARDIANCE, MOUNJARO, AFREZZA.
Industry payments across NE — which companies pay providers there.
